Is CRVS A Good Stock To Buy Now?
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards...
Corvus Pharmaceuticals Inc. (CRVS)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 6,767,584 | $27,138 | 0.34% | |
| 2. | Adams Street Partners Jeffrey Diehl | 3,275,616 | $13,135 | 3.46% | |
| 3. | Biotechnology Value Fund / BVF Inc Mark Lampert | 1,743,712 | $6,992 | +1% | 0.38% |
| 4. | Renaissance Technologies Jim Simons | 875,000 | $3,509 | -16% | 0% |
| 5. | Millennium Management Israel Englander | 381,143 | $1,528 | -69% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.00 | 14,736 | Officer, Director | 1,178,515 | 2019-11-13 | Filing | |
| $2.90 | 272 | Officer, Director | 1,163,779 | 2019-11-12 | Filing | |
| $3.51 | 142,656 | Large Shareholder, Director | 6,767,584 | 2019-08-06 | Filing | |
| $3.51 | 142,656 | Large Shareholder, Director | 6,767,584 | 2019-08-06 | Filing | |
| $3.54 | 2,500 | Officer, Director | 1,163,507 | 2019-08-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.37 | 741,440 | Large Shareholder | 1,389,498 | 2020-07-08 | Filing | |
| $5.25 | 796,622 | Large Shareholder | 2,130,938 | 2020-07-07 | Filing | |
| $4.00 | 1,400,000 | Large Shareholder | 2,927,560 | 2019-07-25 | Filing | |
| $5.01 | 53,240 | Large Shareholder | 4,327,560 | 2019-07-24 | Filing | |
| $5.32 | 39,716 | Large Shareholder | 4,380,800 | 2019-07-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 19,959 | $71 | 0% | |
| 2. | 1,000 | $3 | 0% | |
| 3. | Cutler Group LpCALL | 900 | $0 | 0% |
| 4. | 5,000 | $0 | 0% |
News See All
Should You Buy Corvus Pharmaceuticals, Inc. (CRVS)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful...
Hedge Funds Aren’t Crazy About Corvus Pharmaceuticals, Inc. (CRVS) Anymore
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the second...
Hedge Fund and Insider Trading News: Larry Robbins, Point72 Asset Management, NII Holdings (NIHD), Marchex, Inc. (MCHX), Corvus Pharmaceuticals Inc (CRVS), and More
Larry Robbins is a hedge fund manager and CEO of Glenview Capital Management. He is also well known for his quarterly letters to investors. Robbins has been described as a ‘Growth at a Reasonable Price...
13D Filing: OrbiMed Advisors and Corvus Pharmaceuticals Inc (CRVS)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d-1(e), 240.13d...
Hedge Fund and Insider Trading News: Starboard Value LP, Two Sigma, Rev Group Inc (REVG), Church & Dwight Co., Inc. (CHD), Pfizer Inc. (PFE), and More
(Reuters) - Starboard Value LP, which is looking to replace the entire board of Newell Brands Inc (NWL.N), said on Wednesday three of its nominees would buy about $25 million in Newell stock with their...
Falling Stocks: What is Going on With Corvus Pharmaceuticals Inc (CRVS)?
Corvus Pharmaceuticals Inc (NASDAQ:CRVS) shares have fallen 50% in mid-day trading after the company announced interim results from an ongoing phase 1/1b study demonstrating safety and clinical activity...
What Is Going On In The Financial Markets Today?
“U.S. stocks opened slightly lower on Tuesday as investors fretted over the ability of President Donald Trump to deliver on his policy plans, and the outcome of his potentially tense meeting with Chinese...
Billionaire Hedge Funds
